Shape Therapeutics Inc.

The future of programmable RNA Medicines

Add To Watchlist
General Information
Company Name
Shape Therapeutics Inc.
Founded Year
2018
Location (Offices)
Seattle, United States +1
Founders / Decision Makers
David J. Huss - Chief Scientific Officer (CSO) John Suliman - Co-Founder Lisa Taylor - General Counsel Matt Valentino - Chief People Officer Rafael Ponce - EVP, Preclinical Development Adrian Briggs - Vice President, Head of Platform Technologies Prashant Mali - Co-Founder
Number of Employees
147
Industries
Biotechnology
Funding Stage
Series B
Social Media

Shape Therapeutics Inc. - Company Profile

Shape Therapeutics Inc. is a biotechnology company established in 2018 with a focus on developing programmable RNA medicines to address the genetic causes of diseases. The company's slogan, "The future of programmable RNA Medicines," encapsulates its innovative approach. Its proprietary platform merges AI and RNA technology to create and evaluate numerous therapeutic options, aiming to bring breakthroughs in RNA editing, advanced AAVs, and disruptive gene therapy manufacturing.

With a recent $112.00M Series B investment received on 15 July 2021, Shape Therapeutics Inc. has garnered significant support from notable investors such as New Enterprise Associates, Decheng Capital, Mission BioCapital, Breton Capital Management, Ling Wong, and Willett Advisors LLC. This funding infusion positions the company for further advancement in its mission to design treatments for a wide spectrum of diseases, including rare genetic disorders and conditions like Alzheimer’s and Parkinson’s. Headquartered in the United States, Shape Therapeutics Inc. is shaping the future of RNA medicines with promising potential for transformative outcomes in the biopharmaceutical industry.

Taxonomy: RNA medicines, genetic disorders, neurodegenerative diseases, metabolic diseases, rare genetic diseases, gene editing, gene therapy, RNA editing, next-generation AAVs, therapeutic possibilities, innovations, pharma industry

Funding Rounds & Investors of Shape Therapeutics Inc. (2)

View All
Funding Stage Amount No. Investors Investors Date
Series B $112.00M 6
New Enterprise Associates, investor in Shape Therapeutics Inc.'s Series B round Decheng Capital, investor in Shape Therapeutics Inc.'s Series B round Mission BioCapital, investor in Shape Therapeutics Inc.'s Series B round Breton Capital Management, investor in Shape Therapeutics Inc.'s Series B round
Ling Wong, Willett Advisors LLC 		15 Jul 2021
Series A $35.50M 4
New Enterprise Associates, investor in Shape Therapeutics Inc.'s Series A round CureDuchenne Ventures, investor in Shape Therapeutics Inc.'s Series A round Tectonic Capital, investor in Shape Therapeutics Inc.'s Series A round
Ling Wong 		06 Nov 2019

Latest News of Shape Therapeutics Inc.

View All

No recent news or press coverage available for Shape Therapeutics Inc..

Similar Companies to Shape Therapeutics Inc.

View All
Locanabio, Inc. - Similar company to Shape Therapeutics Inc.
Locanabio, Inc. Creating RNA-targeting gene therapies to treat devastating diseases
ADARx Pharmaceuticals Inc. - Similar company to Shape Therapeutics Inc.
ADARx Pharmaceuticals Inc. Our vision is to provide effective and safe therapeutics to patients who suffer from intractable diseases.
Ascidian Therapeutics - Similar company to Shape Therapeutics Inc.
Ascidian Therapeutics Rewriting RNA
Gene Cradle - Similar company to Shape Therapeutics Inc.
Gene Cradle Developing gene therapy drugs to treat rare genetic diseases and chronic conditions
AIRNA - Similar company to Shape Therapeutics Inc.
AIRNA The next generation of RNA editing therapeutics
Circle Decoration Circle Decoration

Want to dive deeper into Shape Therapeutics Inc.? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now